Skip to main content
. 2022 Mar 29;10:25151355221088157. doi: 10.1177/25151355221088157

Table 3.

Incidence of AEFIs according to the used vaccine during the active reporting survey.

National pharmacovigilance survey
No. of immunized subjects (N = 1000) No. of subjects reporting AEFIs (N = 771) Incidence (%)
Adjuvanted vaccine
 Arepanrix 549 451 82.1
 Pandemrix 359 281 78.3
Non-adjuvanted vaccine
 Panenza 92 39 42.4